Foodconsumer.org

 
USCards.com Bookmark Us
All Food, Diet and Health News 
 
 Misc. News
 Must-Read News
 Letter to Editor
 Featured Products
 Recalls & Alerts
 Consumer Affair
 Non-food Things
 Health Tips
 Interesting Sites
 
 Diet & Health
 Heart & Blood
 Cancer
 Body Weight
 Children & Women
 General Health
 Nutrition
 
 Food & Health
 Food Chemicals
 Biological Agents
 Cooking & Packing
 Technologies
 Agri. & Environ.
 Laws & Politics
 
 General Health
 Drug News
 Diseases
 Mental Health
 Infectious Disease
 Environment
 Lifestyle
 Government
 Other News
 
 Food Consumer
 FC News & Others
Search





Search Foodconsumer & Others


Add to Google
Add to My Yahoo
Newsfeed

foodconsumer.org news feed
Su bmit news[release]



More than 100 credit cards available at uscards.com from uscards.com, you can pick more than 100 credit cards


Diet & Health : Cancer Last Updated: Apr 20, 2011 - 9:38:09 AM


High serum vitamin D cuts lung cancer risk by 70%
By Ben Wasserman
Nov 9, 2008 - 12:42:16 PM

E.mail t.his a.rticle
 P.rinter f.riendly p.age
Get n.ewsletter
 
   
Vitami.n C Lowers Bloo.d Pressur.e

Tarceva effective in treating certain type of lung cancer


Alright, there has been a lot of talking this weekend about an old drug Tarceva that may find new use in treating lung cancer after a press release issued on Friday by OSI Pharmaceuticals Inc and Genentech.

 

The drug makers said a new yet small study showed the drug Tarceva effectively slowed the progression of lung cancer when given immediately after chemotherapy.

 

Another study published early this year but not as widely publicized suggests that taking vitamin D supplements could reduce the risk of lung cancer by 70 percent in young men and women.

 

The details of the drug trial will reportedly be presented at an upcoming medical conference and will be also submitted to federal regulators for approval of Tarceva for expanded use in treating lung cancer.

 

The drug has been Okayed by the U.S. government in 2004 to treat patients with locally advanced or metastatic non-small cell lung cancer, the most common form of lung cancer in the U.S in cases other treatments have failed to stop progression of the disease.

 

An early trial showed that patients receiving Tarceva had a median survival of 6.7 months compared to 4.7 months for those who were given a placebo.

 

This new study is good news that OSI and its partners badly needed.   In early trials, Traceva failed to deliver much of additional benefit when used along with Avastin, a cancer drug made by Genentech.

 

 

High serum vitamin D cuts lung cancer risk in young people by 70 percent

 

Lung cancer is very dangerous and prognosis for the disease is very poor.   Thus no one can afford to wait to develop the disease and then treat it.   According to data from the U.S. government, more than 200,000 people in the U.S. are diagnosed and more than 160,000 die from the disease each year.

 

Is there anything we can do in reality to prevent lung cancer?

 

We have already known that physical activity, diet high in fruits and vegetables, high in nutrients like vitamin C, E, or selenium may reduce the risk of lung cancer.   High exposure to sunlight and or taking vitamin D supplements, getting enough sleep, avoiding stress and fatigue and environmental pollutants may also help.

 

A new study published in the Nov 2008 issue of Cancer Epidemiol Biomarkers Prev. showed once again that high levels of serum 25-hydroxyvitamin D [25(OH)D] level was linked with reduced risk of lung cancer.

 

For the prospective cohort study, Kilkkinen A and colleagues of the National Public Health Institute in Helsinki, Finland looked at data on serum vitamin D levels and cases of lung cancer for 6,937 men and women.   During a maximum follow-up of 24 years, 122 cases of lung cancer were recorded.

 

An association between vitamin D and lung cancer risk was observed for the highest versus lowest tertile with the odds ratio 0.72.  But the researchers said the link was not statistically significant.

 

However, the significant association was found among women and young men and women.

 

For women, those who had highest levels of vitamin D in their blood were 84 percent less likely to develop lung cancer.   For younger participants, those with highest levels were 66 percent less likely to have the disease compared to those with the lowest levels.

 

The researchers concluded that "although there was no overall association between vitamin D and lung cancer risk, women and young participants with a higher level of vitamin D were observed to have a lower lung cancer risk."

 

The study was not a trial, but there is a very good chance that the association is a causal relationship.   Laboratory studies have already yielded evidence suggesting that vitamin D suppresses lung carcinogenesis.





© 2004-2008 by foodconsumer.org unless otherwise specified

Top of Page




Google
 
Web foodconsumer.org

Search Consumer-friendly Health Sites












We have moved to Food Consumer . Org



disclaimer | advertising | jobs | privacy | about us | newsletter | Submit news/articles
link partners: | Buy Viagra | MarketAmerica.com |
Buy a home | Auto Insurance | Mortgage refinancing | DaytonaCPA.com | Take Your Blog to a Higher Level
© Copyright 2004 - 2008 foodconsumer.org All rights reserved

Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only. The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals. Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.